Teacher Retirement System Of Texas Spectrum Pharmaceuticals Inc Transaction History

Teacher Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.27 - $2.42 $31,437 - $59,904	-24,754 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$2.15 - $3.82 $15,480 - $27,504	7,200 Added 41.02%	24,754 $54,000
Q2 2021 Aug 05, 2021	BUY	$2.89 - $4.45 $8,259 - $12,718	2,858 Added 19.45%	17,554 $66,000
Q1 2021 May 11, 2021	BUY	$2.9 - $4.09 $8,662 - $12,216	2,987 Added 25.51%	14,696 $48,000
Q4 2020 Feb 11, 2021	BUY	$3.38 - $5.14 $39,576 - $60,184	11,709 New	11,709 $40,000
Q4 2018 Mar 04, 2019	SELL	$6.39 - $16.99 $70,673 - $187,909	-11,060 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$16.52 - $24.82 $121,488 - $182,526	-7,354 Reduced 39.94%	11,060 $186,000
Q2 2018 Aug 06, 2018	SELL	$14.31 - $21.75 $55,250 - $83,976	-3,861 Reduced 17.33%	18,414 $386,000
Q1 2018 May 08, 2018	SELL	$16.09 - $23.07 $101,125 - $144,994	-6,285 Reduced 22.01%	22,275 $358,000
Q4 2017 Feb 06, 2018	BUY	$13.36 - $20.73 $381,561 - $592,048	28,560	28,560 $541,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.